Global Test Strip Market Research Report- Forecast to 2021

Global Test Strip Market Research Report- Forecast to 2021

ID: MRFR/MED/0201-HCRR | July, 2017 | Region: Global | 150 pages | Half-Cooked Research Reports

Global Test Strip Market by Application (Diagnosis {Urinalysis [UTI, Liver Disease]} Pregnancy Test) Type (Fluorescein, Diabetic Strips, Urine test strip) End Users (Consumers, Hospitals, Clinics, Diagnostic Laboratories) - Volume & Value Forecast to 2021


Market Scenario

Test strip are the most important tools in Point of Care (POC) diagnostics. They helpto achieveprecise and rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others. The Test Strip market is expected to grow at higher growth rate due to Government's Support in various healthcare sectors, High prevalence of incidences of UTIs, Rising Diabetic Population, and various Technological advancements are the major growth drivers of test strip market. However, stringent regulatory policies, Lower adoption of this technology in under developed countries such as Latin American and African Countries, and inadequate reimbursement for test strips may restrict the growth of this market.


Key Players

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market.The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics.


Based on the product type the test strip market by type is divided into urine test strip, diabetic strips, and fluorescein. Diabetic strips segment is expected to grow at high growth rate due to rising government bodies concerns for diabetes across the globe. There is an incessant rise in the number of diabetic people worldwide. According to International Diabetic Federation, there were 415 million people living with diabetes in 2015, and this number is poised to reach 642million by 2040.


Diabetic Population



 


For proper maintenance of the disease, there is a requirement of monitoring the blood glucose level t regular interval. Theses arises need for self-glucose monitoring. Blood glucose test strip is an essential part of self-blood glucose monitoring. The market for blood glucose test strip was estimated at $13.7 billion in 2015 and is expected to reach $18.5 billion by 2020. The growth of the market is driven by launch of advanced test strips based on innovative technology which provide more accurate and reliable results.


Furthermore, based on the applications the test strip market is segmented into disease diagnosis and pregnancy tests. The disease diagnosis segment is further segmented into urinalysis, blood glucose analysis, and ophthalmic diagnostic. The urinalysis segment is consisting of urinary tract infection (UTI), liver disease, kidney diseases, diabetic test, and others.


Based on End users the test strip market is further divided into institutes & research laboratories, hospitals & clinics, diagnostic laboratories, and consumers. The rising demand of the point of care (POC) is expected to drive end users market for global test strip market.


Based on region, North America accounted for the largest share in the global test strip market, followed by Europe and Asia Pacific. The Asia Pacific market is expected to witness the highest growth owing to rising awareness regarding self-monitoring. Furthermore, various players are investing in the Asia Pacific market which is another major factor fueling the market growth.


The global test strip market report provides detail analysis of market in terms of volume of test strip sold and value market. The report also provides the future outlook of the market till 2021. Moreover, the global as well as regional market share of various players based on volume of test strip sold is also analyzed in the report. Lastly, the report provides company profiles of major players in the market.


Scope of the Report


This market research report covers the global test strips market by product, application, functions, end user, and region.


Global Test Strip Markets, By Product Type



  • Urine test strip

  • Diabetic Strips

  • Fluorescein


Global Test Strip Market, By Application



  • Disease Diagnosis

    • Urinalysis

      • Urinary Tract Infection (UTI)

      • Liver Disease

      • Kidney Diseases

      • Diabetic Test

      • Others



    • Blood Glucose Analysis

    • Ophthalmic Diagnostic



  • Pregnancy Test


 


Global Test Strip Market, By Function



  • Visual Test Strips

  • Automated Test Strips


 


Global Test Strip Market, By End Users



  • Institutes & Research Laboratories

  • Hospitals & Clinics

  • Diagnostic Laboratories

  • Consumers


Global Test Strip Market, by Region



  • North America

    • U.S.

    • Canada



  • Europe

    • Germany

    • France

    • U.K.

    • Italy

    • Spain

    • Rest of Europe



  • Asia

    • Japan

    • China

    • India

    • Rest of Asia



Table of Content

1 Introduction

      1.1 Definition

      1.2 Scope of the study

            1.2.1 Research Objectives

            1.2.2 Assumptions & Limitations

      1.3 Market Structure

2 Research Methodology

      2.1 Research Process

      2.2 Primary Research

      2.3 Secondary Research

      2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

      4.1 Introduction

      4.2 Growth Drivers

            4.2.1 Government's Support

            4.2.2 Technological advancements

            4.2.3 High prevalence of UTIs

            4.2.4 Rising diabetic population

            4.2.5 Technological advancements

            4.2.6 Players engaged in creating awareness

      4.3 Growth Barriers

            4.3.1 Varied regulatory stringency across globe

            4.3.2 Lower rate of adoption in under developed countries

            4.3.3 Inadequate reimbursement for test strips

      4.4 Market Opportunities

            4.4.1 Rising Point of Care

            4.4.2 Rising Disposable Income Of Emerging Economies

      4.5 Macroecnomical Indicators

5 Market Analysis

      5.1 Marketing Mix

      5.2 Porter's Five Force

      5.3 Supply Chain Analysis

      5.4 Value chain Analysis

6 Global Test Strip Markets, By Product Type

      6.1 Introduction

      6.2 Urine test strip

      6.3 Diabetic Strips

      6.4 Fluorescein

7 Global Test Strip Market, By Application

      7.1 Introduction

      7.2 Disease Diagnosis

            7.2.1 Urinalysis

                7.2.1.1 Urinary Tract Infection (UTI)

                7.2.1.2 Liver Disease

                7.2.1.3 Kidney Diseases

                7.2.1.4 Diabetic Test

                7.2.1.5 Others

            7.2.2 Blood Glucose Analysis

            7.2.3 Ophthalmic Diagnostic

      7.3 Pregnancy Test

8 Global Test Strip Market, By Function

      8.1 Introduction

      8.2 Visual Test Strips

      8.3 Automated Test Strips

9 Global Test Strip Market, By End Users

      9.1 Introduction

      9.2 Institutes & Research Laboratories

      9.3 Hospitals & Clinics

      9.4 Diagnostic Laboratories

      9.5 Consumers

10 Global Test Strip Market, by Region

      10.1 Introduction

      10.2 North America

            10.2.1 U.S.

            10.2.2 Canada

      10.3 Europe

            10.3.1 Germany

            10.3.2 France

            10.3.3 U.K.

            10.3.4 Italy

            10.3.5 Spain

            10.3.6 Rest of Europe

      10.4 Asia

            10.4.1 Japan

            10.4.2 China

            10.4.3 India

            10.4.4 Rest of Asia

      10.5 Rest of the World

11 Competitive Landscape

      11.1 Market Share Analysis

            11.1.1 Global

            11.1.2 North America

            11.1.3 Europe

            11.1.4 Asia-Pacific

            11.1.5 Rest of the World

      11.2 Competitive/Strategic Scenario

            11.2.1 Mergers Acquisitions

            11.2.2 Collaborations

            11.2.3 Expansion

            11.2.4 New Product Launches

12 Company Profiles

      12.1 Introduction

      12.2 Abbott Laboratories

            12.2.1 Overview

            12.2.2 Financials

            12.2.3 Product Portfolio

            12.2.4 Recent Developments

            12.2.5 Business Strategies

      12.3 Arkray Inc.

            12.3.1 Overview

            12.3.2 Financials

            12.3.3 Product Portfolio

            12.3.4 Recent Developments

            12.3.5 Business Strategies

      12.4 Ascensia Diabetes Care Holdings Ag (Previously Known As Bayer Diabetes Care)

            12.4.1 Overview

            12.4.2 Financials

            12.4.3 Product Portfolio

            12.4.4 Recent Developments

            12.4.5 Business Strategies

      12.5 B. Braun Melsungen AG

            12.5.1 Overview

            12.5.2 Financials

            12.5.3 Product Portfolio

            12.5.4 Recent Developments

            12.5.5 Business Strategies

      12.6 Chiltern Medicare Ltd

            12.6.1 Overview

            12.6.2 Financials

            12.6.3 Product Portfolio

            12.6.4 Recent Developments

            12.6.5 Business Strategies

      12.7 Henry Schein

            12.7.1 Overview

            12.7.2 Financials

            12.7.3 Product Portfolio

            12.7.4 Recent Developments

            12.7.5 Business Strategies

      12.8 Lifeassay Diagnostics (Pty)

            12.8.1 Overview

            12.8.2 Financials

            12.8.3 Product Portfolio

            12.8.4 Recent Developments

            12.8.5 Business Strategies

      12.9 Lifescan, Inc. (a Johnson & Johnson company)

            12.9.1 Overview

            12.9.2 Financials

            12.9.3 Product Portfolio

            12.9.4 Recent Developments

            12.9.5 Business Strategies

      12.10 Roche Diagnostics

            12.10.1 Overview

            12.10.2 Financials

            12.10.3 Product Portfolio

            12.10.4 Recent Developments

            12.10.5 Business Strategies

      12.11 Siemens Healthcare

            12.11.1 Overview

            12.11.2 Financials

            12.11.3 Product Portfolio

            12.11.4 Recent Developments

            12.11.5 Business Strategies

      12.12 Taidoc Technology Corporation

            12.12.1 Overview

            12.12.2 Financials

            12.12.3 Product Portfolio

            12.12.4 Recent Developments

            12.12.5 Business Strategies

      12.13 Teco Diagnostics

            12.13.1 Overview

            12.13.2 Financials

            12.13.3 Product Portfolio

            12.13.4 Recent Developments

            12.13.5 Business Strategies